Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury
Go back to Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury| (NASDAQ: ACOG) | Delayed: 6.75 -0.16 (2.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.91 | 52 Week High | $ | |||
| Open | $7.00 | 52 Week Low | $ | |||
| Day High | $7.03 | P/E | N/A | |||
| Day Low | $6.73 | EPS | $ | |||
| Volume | 11,784 | |||||
